Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu
- 19 September 2007
- journal article
- Published by Springer Science and Business Media LLC in Cell Biology and Toxicology
- Vol. 24 (1), 1-10
- https://doi.org/10.1007/s10565-007-9010-5
Abstract
Overexpression of HER2/neu is associated with drug resistance and poor outcome in breast cancer. Solamargine (SM), a glycoalkaloid purified from the herb Solanum incanum, exhibits HER2/neu gene modulation of HER2/neu high-expressing human breast cancer cell line ZR-75-1. SM downregulation of HER2/neu gene expression was determined by RT-PCR and Southern hybridization. Additionally, the membrane-bound HER2/neu receptor in highly HER2/neu-expressing breast cancer cells was determined by radioimmunoassay, immunocytochemistry, fluorescent immunocytochemistry, and flow cytometry. SM significantly decreased the number of HER2/neu receptors on the cell membrane. Methotrexate (MTX), 5-florouracil (5-Fu), and cisplatin (CDDP) are commonly used for breast carcinoma treatment in clinics; however, patients with HER2/neu overexpression exhibit resistance to these anticancer drugs. Notably, combination of MTX, 5-Fu, and CDDP with SM individually increased the susceptibility of breast cancer cells to these chemotherapeutic agents. Experimental results indicated that downregulation of HER2/neu by SM might be an effective strategy for enhancing drug susceptibility of breast cancer cells expressing high levels of HER2/neu.Keywords
This publication has 25 references indexed in Scilit:
- The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detectionGynecologic Oncology, 2005
- Action of solamargine on TNFs and cisplatin-resistant human lung cancer cellsBiochemical and Biophysical Research Communications, 2004
- Her-2/neu and Topoisomerase iiα in Breast CancerBreast Cancer Research and Treatment, 2003
- Anticancer activity evaluation of the Solanum glycoalkaloid solamargine: Triggering apoptosis in human hepatoma cellsBiochemical Pharmacology, 2000
- Sensitivity of c‐erbB Positive Cells to a Ligand Toxin and Its Utility in Purging Breast Cancer Cells from Peripheral Blood Stem Cell (PBSC) CollectionsThe International Journal of Cell Cloning, 2000
- Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast CancerThe American Journal of Pathology, 2000
- Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells.International Journal of Oncology, 2000
- The Rhamnose Moiety of Solamargine Plays a Crucial Role in Triggering Cell Death by ApoptosisBiochemical and Biophysical Research Communications, 1998
- The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implicationsBiochemistry and Cell Biology, 1997
- THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITYBiochemical Journal, 1963